iCLAS™ for Persistent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 215 participants.

Also called NCT04061603

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 215 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04061603
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Belgium, Canada, Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04061603. Allocation not applicable; no masking; primary purpose treatment. Start 2019-12-09 (actual); primary completion 2023-08-30 (actual). Results posted on 2026-08-06.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
iCLAS™ for Persistent Atrial Fibrillation
Condition
Persistent Atrial Fibrillation
Intervention (Device)
Adagio AF Cryoablation System (iCLAS™)
Lead sponsor
Adagio Medical (class: industry)

Record details

Record id
cardio:ct-nct04061603
Content hash
297dbc51f70d52e7e60ec431dc3d56db7dd1cca65376c2a48792f56d34dd1e88